Skip to main content
OpenTrials
Completed

NCT Number: NCT02712606

Accuracy of Pulse Oximeter With Hypoxemic Measurements

A study about accuracy of pulse oximeter with hypoxemic measurements (Blue sensor, Masimo, Irvine, CA, USA) in children with cyanotic congenital heart disease

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Hospital

Seoul, 110-744, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clinical diagnosis of cyanotic congenital heart disease
  • weight 2.5kg to 30kg
  • undergoing general anesthesia
  • preoperative SpO2<97%

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. accuracy of pulse oximetry using blue sensor

    Time frame: From the start of anesthetic induction until discharge from hospital, assessed up to 1 week.

    Each arterial blood gas sample and pulse oximeter oxygen saturation (SpO2) from blue sensor pulse oximetry are simultaneously obtained if the SpO2 is <97%.

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

A Study About Accuracy of Pulse Oximeter With Hypoxemic Measurements (Blue Sensor) in Children With Cyanotic Congenital Heart Disease

Acronym: bluesensor

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 18, 2016
Registry last updated
Apr 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.